[
  {
    "ts": "2026-01-25T10:30:00+00:00",
    "headline": "Can Trump and Big Pharma Get the World to Pay More for Drugs?",
    "summary": "Americans pay about three times what other wealthy nations do for branded prescription drugs.  For years, policymakers have tried to fix this by cutting U.S. drug prices directly.  President Trump has pushed a different idea: make foreign countries pay more so Americans can pay less.",
    "url": "https://www.wsj.com/health/pharma/can-trump-and-big-pharma-get-the-world-to-pay-more-for-drugs-bfe5e31d?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "08bedcdd-dbd1-3946-a63d-750aff81c929",
      "content": {
        "id": "08bedcdd-dbd1-3946-a63d-750aff81c929",
        "contentType": "STORY",
        "title": "Can Trump and Big Pharma Get the World to Pay More for Drugs?",
        "description": "",
        "summary": "Americans pay about three times what other wealthy nations do for branded prescription drugs.  For years, policymakers have tried to fix this by cutting U.S. drug prices directly.  President Trump has pushed a different idea: make foreign countries pay more so Americans can pay less.",
        "pubDate": "2026-01-25T10:30:00Z",
        "displayTime": "2026-01-25T10:30:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/08bedcdd-dbd1-3946-a63d-750aff81c929/can-trump-and-big-pharma-get.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/b8097875bd09bcaba1a86612c4e419dd",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YZ17NAqX3aWE2bEoVrwJDw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/b8097875bd09bcaba1a86612c4e419dd.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cb3XimED6r.IFAykjh.wyQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/b8097875bd09bcaba1a86612c4e419dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/can-trump-and-big-pharma-get-the-world-to-pay-more-for-drugs-bfe5e31d?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "AZNCF"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "MDGL"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-25T19:38:18+00:00",
    "headline": "Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership",
    "summary": "Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain’s GSK and Japan’s Shionogi said Pfizer Inc. (NYSE:PFE) will exit their HIV-focused joint venture, ViiV Healthcare. The transaction values Pfizer’s exit at about $1.9 billion and sharply increases Shionogi’s stake in the business. Under the deal, […]",
    "url": "https://finance.yahoo.com/news/pfizer-exit-viiv-healthcare-gsk-193818772.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "b2686701-f032-3302-b7f8-b32dfae2878f",
      "content": {
        "id": "b2686701-f032-3302-b7f8-b32dfae2878f",
        "contentType": "STORY",
        "title": "Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is included among Dividend Contenders List: Top 20 Stocks. Reuters reported on January 20 that Britain’s GSK and Japan’s Shionogi said Pfizer Inc. (NYSE:PFE) will exit their HIV-focused joint venture, ViiV Healthcare. The transaction values Pfizer’s exit at about $1.9 billion and sharply increases Shionogi’s stake in the business. Under the deal, […]",
        "pubDate": "2026-01-25T19:38:18Z",
        "displayTime": "2026-01-25T19:38:18Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Pfizer to Exit ViiV Healthcare as GSK and Shionogi Reshape Ownership",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UKiv8LHLxutAA7dDIzr_pw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1v0rnd.QZj0de1gLzaNuAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-exit-viiv-healthcare-gsk-193818772.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-exit-viiv-healthcare-gsk-193818772.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "SGIOF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]